Brief: CTI BioPharma Reports Q3 Loss Per Share Of $0.15

CTI Biopharma

10/11/2020 21:11

Nov 10 (Reuters) - CTI Biopharma Corp  CTIC.O :
    * CTI BIOPHARMA REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS
    * Q3 LOSS PER SHARE $0.15
    * AS OF SEPTEMBER 30, 2020, CASH, CASH EQUIVALENTS AND
SHORT-TERM
INVESTMENTS TOTALED $57.4 MILLION
    * EXPECT CURRENT CASH, CASH EQUIVALENTS AND SHORT-TERM
INVESTMENTS
WILL ENABLE TO FUND OPERATIONS INTO Q4 OF 2021
    * Q3 EARNINGS PER SHARE VIEW $-0.15 -- REFINITIV IBES DATA
    * NO REVENUES WERE RECOGNIZED FOR THREE AND NINE MONTHS
ENDED
SEPTEMBER 30, 2020
    * Q3 REVENUE VIEW $0.00 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nPn97ypK1a 
Further company coverage:  CTIC.O 

 ((Reuters.Briefs@thomsonreuters.com;))